| Jun 3, 2025 |
Jun 3, 2025 |
Immunome Inc.
|
Director |
Buy |
91.3
|
+5,000
|
15.92%
|
✗
|
$46.9K |
| Mar 25, 2025 |
Mar 26, 2025 |
Immunome Inc.
|
Director |
Buy |
95.0
|
+7,800
|
33.03%
|
✗
|
$60.7K |
| Mar 24, 2025 |
Mar 25, 2025 |
Immunome Inc.
|
Director |
Buy |
95.0
|
+7,000
|
42.13%
|
✗
|
$57.5K |
| Aug 16, 2024 |
Aug 19, 2024 |
Immunome Inc.
|
Director |
Buy |
95.0
|
+7,000
|
72.80%
|
✗
|
$97.6K |
| May 21, 2024 |
May 22, 2024 |
Immunome Inc.
|
Director |
Buy |
91.3
|
+2,000
|
26.26%
|
✗
|
$27.1K |
| May 20, 2024 |
May 21, 2024 |
BIOMARIN PHARMACEUTICAL INC
|
Director |
Sell |
47.5
|
-1,202
|
-0.17%
|
✗
|
$92.6K |
| May 9, 2024 |
May 13, 2024 |
BIOMARIN PHARMACEUTICAL INC
|
Director |
Sell |
32.5
|
-40,000
|
-3.23%
|
✓
|
$3.3M |
| Apr 11, 2024 |
Apr 15, 2024 |
BIOMARIN PHARMACEUTICAL INC
|
Director |
Sell |
32.5
|
-40,000
|
-3.23%
|
✓
|
$3.6M |
| Mar 15, 2024 |
Mar 19, 2024 |
BIOMARIN PHARMACEUTICAL INC
|
Director |
Sell |
16.3
|
-85,209
|
-10.55%
|
✗
|
$7.1M |
| Mar 5, 2024 |
Mar 7, 2024 |
BIOMARIN PHARMACEUTICAL INC
|
Director |
Sell |
40.0
|
-2,000
|
-0.25%
|
✗
|
$172.2K |
| Feb 27, 2024 |
Feb 29, 2024 |
BIOMARIN PHARMACEUTICAL INC
|
Director |
Sell |
95.0
|
+142,601
|
21.38%
|
✗
|
$90.4K |
| Jan 18, 2024 |
Feb 12, 2024 |
BIOMARIN PHARMACEUTICAL INC
|
Director |
Sell |
40.0
|
-29,960
|
-1.95%
|
✓
|
$2.7M |
| Jan 8, 2024 |
Jan 11, 2024 |
BIOMARIN PHARMACEUTICAL INC
|
Director |
Sell |
40.0
|
-19,950
|
-1.29%
|
✓
|
$1.9M |
| Dec 21, 2023 |
Dec 22, 2023 |
BIOMARIN PHARMACEUTICAL INC
|
Director |
Sell |
42.5
|
-10,000
|
-1.46%
|
✓
|
$939.9K |
| Oct 4, 2023 |
Dec 12, 2023 |
BIOMARIN PHARMACEUTICAL INC
|
Director |
Buy |
60.0
|
+2,380
|
0.36%
|
✗
|
$855.7 |
| Aug 7, 2023 |
Aug 9, 2023 |
BIOMARIN PHARMACEUTICAL INC
|
CEO |
Sell |
20.0
|
-10,000
|
-1.47%
|
✗
|
$882.1K |
| May 12, 2023 |
May 16, 2023 |
BIOMARIN PHARMACEUTICAL INC
|
CEO |
Sell |
17.5
|
-39,981
|
-5.55%
|
✗
|
$3.8M |
| May 11, 2023 |
May 15, 2023 |
BIOMARIN PHARMACEUTICAL INC
|
CEO |
Sell |
32.5
|
-30,000
|
-4.26%
|
✓
|
$2.8M |
| Apr 28, 2023 |
May 11, 2023 |
BIOMARIN PHARMACEUTICAL INC
|
CEO |
Sell |
35.0
|
-59,683
|
-2.06%
|
✓
|
$5.7M |
| Apr 10, 2023 |
Apr 12, 2023 |
BIOMARIN PHARMACEUTICAL INC
|
CEO |
Sell |
42.5
|
-10,000
|
-1.46%
|
✓
|
$995.6K |
| Apr 6, 2023 |
Apr 10, 2023 |
BIOMARIN PHARMACEUTICAL INC
|
CEO |
Sell |
42.5
|
-10,000
|
-1.46%
|
✓
|
$961.3K |
| Mar 15, 2023 |
Mar 17, 2023 |
BIOMARIN PHARMACEUTICAL INC
|
CEO |
Sell |
16.3
|
-61,960
|
-8.43%
|
✗
|
$9.1M |
| Mar 10, 2023 |
Mar 14, 2023 |
BIOMARIN PHARMACEUTICAL INC
|
CEO |
Sell |
40.0
|
-23,000
|
-1.85%
|
✓
|
$2.1M |
| Feb 7, 2023 |
Feb 14, 2023 |
BIOMARIN PHARMACEUTICAL INC
|
CEO |
Sell |
36.3
|
-21,000
|
-2.31%
|
✓
|
$2.3M |
| Jan 13, 2023 |
Jan 18, 2023 |
BIOMARIN PHARMACEUTICAL INC
|
CEO |
Sell |
36.3
|
-20,000
|
-2.20%
|
✓
|
$2.2M |
| Dec 13, 2022 |
Dec 15, 2022 |
BIOMARIN PHARMACEUTICAL INC
|
CEO |
Sell |
47.5
|
-1,000
|
-0.18%
|
✗
|
$106.9K |
| Nov 2, 2022 |
Dec 6, 2022 |
BIOMARIN PHARMACEUTICAL INC
|
CEO |
Sell |
40.0
|
-1,400
|
-0.25%
|
✗
|
$147.4K |
| Oct 31, 2022 |
Nov 1, 2022 |
BIOMARIN PHARMACEUTICAL INC
|
CEO |
Sell |
40.0
|
-1,500
|
-0.26%
|
✗
|
$129.8K |
| Oct 14, 2022 |
Oct 18, 2022 |
BIOMARIN PHARMACEUTICAL INC
|
CEO |
Sell |
45.0
|
-4,000
|
-0.69%
|
✓
|
$359.6K |
| Aug 12, 2022 |
Aug 16, 2022 |
BIOMARIN PHARMACEUTICAL INC
|
CEO |
Sell |
42.5
|
-7,000
|
-1.20%
|
✓
|
$664.6K |
| Apr 29, 2022 |
May 9, 2022 |
BIOMARIN PHARMACEUTICAL INC
|
CEO |
Sell |
36.3
|
-29,659
|
-2.31%
|
✓
|
$2.5M |
| Apr 28, 2022 |
May 2, 2022 |
BIOMARIN PHARMACEUTICAL INC
|
CEO |
Sell |
36.3
|
-25,000
|
-2.65%
|
✓
|
$2.1M |
| Apr 18, 2022 |
Apr 20, 2022 |
BIOMARIN PHARMACEUTICAL INC
|
CEO |
Sell |
32.5
|
-20,000
|
-3.32%
|
✓
|
$1.6M |
| Apr 14, 2022 |
Apr 18, 2022 |
BIOMARIN PHARMACEUTICAL INC
|
CEO |
Sell |
42.5
|
-10,000
|
-1.69%
|
✓
|
$836.6K |
| Mar 15, 2022 |
Mar 17, 2022 |
BIOMARIN PHARMACEUTICAL INC
|
CEO |
Sell |
27.5
|
-3,586
|
-0.61%
|
✗
|
$3.4M |
| Mar 10, 2022 |
Mar 14, 2022 |
BIOMARIN PHARMACEUTICAL INC
|
CEO |
Sell |
32.5
|
-30,000
|
-3.14%
|
✓
|
$2.3M |
| Dec 21, 2021 |
Jan 14, 2022 |
BIOMARIN PHARMACEUTICAL INC
|
CEO |
Sell |
45.0
|
-9,900
|
-0.85%
|
✓
|
$875.4K |
| Dec 10, 2021 |
Dec 17, 2021 |
BIOMARIN PHARMACEUTICAL INC
|
CEO |
Sell |
40.0
|
-12,700
|
-1.08%
|
✓
|
$1M |
| Sep 9, 2021 |
Dec 2, 2021 |
BIOMARIN PHARMACEUTICAL INC
|
CEO |
Sell |
40.0
|
-1,450
|
-0.26%
|
✗
|
$126.9K |
| May 10, 2021 |
May 12, 2021 |
BIOMARIN PHARMACEUTICAL INC
|
CEO |
Sell |
42.5
|
-8,513
|
-1.52%
|
✓
|
$658K |
| Apr 30, 2021 |
May 10, 2021 |
BIOMARIN PHARMACEUTICAL INC
|
CEO |
Sell |
36.3
|
-49,659
|
-2.32%
|
✓
|
$3.9M |
| Apr 22, 2021 |
Apr 26, 2021 |
BIOMARIN PHARMACEUTICAL INC
|
CEO |
Sell |
36.3
|
-20,000
|
-2.29%
|
✓
|
$1.6M |
| Mar 22, 2021 |
Mar 23, 2021 |
BIOMARIN PHARMACEUTICAL INC
|
CEO |
Sell |
30.0
|
-5,519
|
-0.99%
|
✗
|
$433.4K |
| Mar 15, 2021 |
Mar 17, 2021 |
BIOMARIN PHARMACEUTICAL INC
|
CEO |
Sell |
87.5
|
+12,365
|
2.28%
|
✗
|
$2.3M |
| Mar 4, 2021 |
Mar 15, 2021 |
BIOMARIN PHARMACEUTICAL INC
|
CEO |
Sell |
40.0
|
-13,900
|
-1.21%
|
✓
|
$1.1M |
| Feb 19, 2021 |
Feb 22, 2021 |
BIOMARIN PHARMACEUTICAL INC
|
CEO |
Sell |
42.5
|
-7,000
|
-1.27%
|
✓
|
$585.1K |
| Feb 18, 2021 |
Feb 19, 2021 |
BIOMARIN PHARMACEUTICAL INC
|
CEO |
Sell |
42.5
|
-7,000
|
-1.27%
|
✓
|
$595.6K |
| Feb 17, 2021 |
Feb 18, 2021 |
BIOMARIN PHARMACEUTICAL INC
|
CEO |
Sell |
42.5
|
-8,000
|
-1.45%
|
✓
|
$676.3K |
| Jan 28, 2021 |
Feb 1, 2021 |
BIOMARIN PHARMACEUTICAL INC
|
CEO |
Sell |
40.0
|
-16,667
|
-1.95%
|
✓
|
$1.4M |
| Jan 27, 2021 |
Jan 28, 2021 |
BIOMARIN PHARMACEUTICAL INC
|
CEO |
Sell |
42.5
|
-8,333
|
-1.51%
|
✓
|
$712.4K |
| Jul 9, 2020 |
Dec 30, 2020 |
BIOMARIN PHARMACEUTICAL INC
|
CEO |
Sell |
45.0
|
-3,425
|
-0.63%
|
✓
|
$265.4K |
| Nov 10, 2020 |
Nov 12, 2020 |
INCYTE CORP
|
Director |
Sell |
22.5
|
-798
|
-8.45%
|
✗
|
$66.2K |
| May 8, 2020 |
May 12, 2020 |
BIOMARIN PHARMACEUTICAL INC
|
CEO |
Sell |
32.5
|
-20,000
|
-3.53%
|
✓
|
$1.8M |
| Apr 30, 2020 |
May 5, 2020 |
BIOMARIN PHARMACEUTICAL INC
|
CEO |
Sell |
45.0
|
-8,661
|
-0.75%
|
✓
|
$797.5K |
| Apr 27, 2020 |
Apr 29, 2020 |
BIOMARIN PHARMACEUTICAL INC
|
CEO |
Sell |
32.5
|
-40,000
|
-4.52%
|
✓
|
$3.9M |
| Apr 9, 2020 |
Apr 13, 2020 |
BIOMARIN PHARMACEUTICAL INC
|
CEO |
Sell |
42.5
|
-10,000
|
-1.80%
|
✓
|
$790.6K |
| Mar 20, 2020 |
Mar 24, 2020 |
BIOMARIN PHARMACEUTICAL INC
|
CEO |
Sell |
20.0
|
-13,128
|
-2.35%
|
✗
|
$959K |
| Mar 13, 2020 |
Mar 17, 2020 |
BIOMARIN PHARMACEUTICAL INC
|
CEO |
Sell |
92.5
|
+13,898
|
2.55%
|
✗
|
$2.6M |
| Mar 3, 2020 |
Mar 11, 2020 |
BIOMARIN PHARMACEUTICAL INC
|
CEO |
Sell |
42.5
|
-9,970
|
-1.17%
|
✓
|
$892.4K |
| Feb 3, 2020 |
Feb 5, 2020 |
BIOMARIN PHARMACEUTICAL INC
|
CEO |
Sell |
42.5
|
-10,000
|
-1.93%
|
✓
|
$835K |
| Jan 14, 2020 |
Jan 16, 2020 |
BIOMARIN PHARMACEUTICAL INC
|
CEO |
Sell |
42.5
|
-8,000
|
-1.55%
|
✓
|
$703.6K |
| Jan 7, 2020 |
Jan 9, 2020 |
BIOMARIN PHARMACEUTICAL INC
|
CEO |
Sell |
45.0
|
-7,000
|
-0.83%
|
✓
|
$593.1K |
| Dec 26, 2019 |
Dec 30, 2019 |
BIOMARIN PHARMACEUTICAL INC
|
CEO |
Sell |
42.5
|
-8,630
|
-1.02%
|
✓
|
$690.1K |
| Nov 5, 2019 |
Nov 26, 2019 |
BIOMARIN PHARMACEUTICAL INC
|
CEO |
Sell |
45.0
|
-10,440
|
-0.89%
|
✓
|
$775.2K |
| Oct 25, 2019 |
Oct 29, 2019 |
BIOMARIN PHARMACEUTICAL INC
|
CEO |
Sell |
45.0
|
-5,000
|
-0.97%
|
✓
|
$347.8K |
| Aug 1, 2019 |
Aug 5, 2019 |
INCYTE CORP
|
Director |
Sell |
22.5
|
-1,724
|
-19.64%
|
✗
|
$146.7K |
| May 10, 2019 |
May 14, 2019 |
BIOMARIN PHARMACEUTICAL INC
|
CEO |
Sell |
42.5
|
-10,000
|
-1.93%
|
✓
|
$825.2K |
| May 9, 2019 |
May 13, 2019 |
BIOMARIN PHARMACEUTICAL INC
|
CEO |
Sell |
45.0
|
-4,000
|
-0.78%
|
✓
|
$327.9K |
| Apr 30, 2019 |
May 9, 2019 |
BIOMARIN PHARMACEUTICAL INC
|
CEO |
Sell |
46.3
|
-3,691
|
-0.44%
|
✓
|
$328.6K |
| Apr 26, 2019 |
Apr 30, 2019 |
BIOMARIN PHARMACEUTICAL INC
|
CEO |
Sell |
47.5
|
-3,000
|
-0.59%
|
✓
|
$248.6K |
| Apr 11, 2019 |
Apr 15, 2019 |
BIOMARIN PHARMACEUTICAL INC
|
CEO |
Sell |
45.0
|
-4,000
|
-0.78%
|
✓
|
$356.5K |
| Apr 8, 2019 |
Apr 9, 2019 |
BIOMARIN PHARMACEUTICAL INC
|
CEO |
Sell |
45.0
|
-3,000
|
-0.59%
|
✓
|
$275.6K |
| Apr 5, 2019 |
Apr 9, 2019 |
BIOMARIN PHARMACEUTICAL INC
|
CEO |
Sell |
45.0
|
-3,000
|
-0.59%
|
✓
|
$280.1K |
| Mar 22, 2019 |
Mar 26, 2019 |
BIOMARIN PHARMACEUTICAL INC
|
CEO |
Sell |
36.3
|
-17,127
|
-2.03%
|
✓
|
$1.5M |
| Mar 15, 2019 |
Mar 19, 2019 |
BIOMARIN PHARMACEUTICAL INC
|
CEO |
Sell |
70.0
|
+2,637
|
0.23%
|
✓
|
$3M |
| Mar 13, 2019 |
Mar 14, 2019 |
BIOMARIN PHARMACEUTICAL INC
|
CEO |
Sell |
45.0
|
-3,000
|
-0.58%
|
✓
|
$280.3K |
| Mar 11, 2019 |
Mar 13, 2019 |
BIOMARIN PHARMACEUTICAL INC
|
CEO |
Sell |
42.5
|
-9,000
|
-1.06%
|
✓
|
$810.5K |
| Mar 7, 2019 |
Mar 8, 2019 |
BIOMARIN PHARMACEUTICAL INC
|
CEO |
Sell |
45.0
|
-4,000
|
-0.78%
|
✓
|
$363.1K |
| Mar 1, 2019 |
Mar 5, 2019 |
BIOMARIN PHARMACEUTICAL INC
|
CEO |
Sell |
92.5
|
+40,411
|
8.60%
|
✗
|
$465.2K |
| Feb 27, 2019 |
Feb 28, 2019 |
BIOMARIN PHARMACEUTICAL INC
|
CEO |
Sell |
45.0
|
-4,000
|
-0.84%
|
✓
|
$367.1K |
| Feb 21, 2019 |
Feb 22, 2019 |
BIOMARIN PHARMACEUTICAL INC
|
CEO |
Sell |
45.0
|
-3,000
|
-0.63%
|
✓
|
$270.4K |
| Feb 14, 2019 |
Feb 15, 2019 |
BIOMARIN PHARMACEUTICAL INC
|
CEO |
Sell |
45.0
|
-4,000
|
-0.84%
|
✓
|
$380.8K |
| Feb 5, 2019 |
Feb 7, 2019 |
BIOMARIN PHARMACEUTICAL INC
|
CEO |
Sell |
45.0
|
-4,000
|
-0.84%
|
✓
|
$394.5K |
| Jan 22, 2019 |
Jan 24, 2019 |
BIOMARIN PHARMACEUTICAL INC
|
CEO |
Sell |
45.0
|
-3,000
|
-0.63%
|
✓
|
$290.5K |
| Jan 14, 2019 |
Jan 15, 2019 |
BIOMARIN PHARMACEUTICAL INC
|
CEO |
Sell |
45.0
|
-4,000
|
-0.84%
|
✓
|
$375.2K |
| Jan 10, 2019 |
Jan 11, 2019 |
BIOMARIN PHARMACEUTICAL INC
|
CEO |
Sell |
45.0
|
-3,000
|
-0.63%
|
✓
|
$271.7K |
| Jan 8, 2019 |
Jan 10, 2019 |
BIOMARIN PHARMACEUTICAL INC
|
CEO |
Sell |
42.5
|
-6,000
|
-1.26%
|
✓
|
$549.5K |
| Jan 7, 2019 |
Jan 9, 2019 |
BIOMARIN PHARMACEUTICAL INC
|
CEO |
Sell |
45.0
|
-3,000
|
-0.63%
|
✓
|
$262.7K |
| Dec 28, 2018 |
Jan 2, 2019 |
BIOMARIN PHARMACEUTICAL INC
|
CEO |
Sell |
45.0
|
-3,000
|
-0.63%
|
✓
|
$252.1K |
| Dec 26, 2018 |
Dec 27, 2018 |
BIOMARIN PHARMACEUTICAL INC
|
CEO |
Sell |
45.0
|
-4,000
|
-0.84%
|
✓
|
$322K |
| Nov 19, 2018 |
Dec 18, 2018 |
BIOMARIN PHARMACEUTICAL INC
|
CEO |
Sell |
47.5
|
-2,700
|
-0.57%
|
✓
|
$185.3K |
| Dec 12, 2018 |
Dec 14, 2018 |
BIOMARIN PHARMACEUTICAL INC
|
CEO |
Sell |
48.8
|
-2,000
|
-0.42%
|
✓
|
$186.2K |
| Nov 8, 2018 |
Nov 9, 2018 |
INCYTE CORP
|
Director |
Buy |
95.0
|
+1,000
|
17.64%
|
✗
|
$68.8K |
| Nov 2, 2018 |
Nov 5, 2018 |
BIOMARIN PHARMACEUTICAL INC
|
CEO |
Sell |
48.8
|
-1,500
|
-0.32%
|
✓
|
$146.8K |
| Nov 1, 2018 |
Nov 2, 2018 |
BIOMARIN PHARMACEUTICAL INC
|
CEO |
Sell |
45.0
|
-4,000
|
-0.84%
|
✓
|
$370.2K |
| Oct 3, 2018 |
Oct 5, 2018 |
BIOMARIN PHARMACEUTICAL INC
|
CEO |
Sell |
48.8
|
-1,500
|
-0.32%
|
✓
|
$149K |
| Sep 24, 2018 |
Sep 24, 2018 |
IMMUNIC, INC.
|
Director |
Sell |
27.5
|
-26,619
|
-59.00%
|
✗
|
$8K |
| Sep 13, 2018 |
Sep 17, 2018 |
IMMUNIC, INC.
|
Director |
Sell |
27.5
|
-20,000
|
-30.71%
|
✗
|
$9.4K |
| Sep 4, 2018 |
Sep 6, 2018 |
BIOMARIN PHARMACEUTICAL INC
|
CEO |
Sell |
48.8
|
-1,500
|
-0.32%
|
✓
|
$147.2K |
| Jul 23, 2018 |
Jul 25, 2018 |
BIOMARIN PHARMACEUTICAL INC
|
CEO |
Sell |
48.8
|
-1,500
|
-0.32%
|
✓
|
$152.5K |